Metastasectomy in stage IV melanoma: A National Cancer Database Analysis - 22/08/19
Marcus L. Elias, BS, Department of Dermatology and Dermatopathology, Rutgers New Jersey Medical School, Newark, NJ; Sara Behbahani, MS, Department of Dermatology and Dermatopathology, Rutgers New Jersey Medical School, Newark, NJ; Spandana Maddukuri, BS, Department of Dermatology and Dermatopathology, Rutgers New Jersey Medical School, Newark, NJ; Ann M. John, MD, Department of Dermatology and Dermatopathology, Rutgers New Jersey Medical School, Newark, NJ; Robert A. Schwartz, MD, MPH, Department of Dermatology and Dermatopathology, Rutgers New Jersey Medical School, Newark, NJ; William C. Lambert, MD, PhD, Department of Dermatology and Dermatopathology, Rutgers New Jersey Medical School, Newark, NJ
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 81 - N° 4S1
P. AB94 - octobre 2019 Retour au numéro
Article précédent
- Metaanalysis of clinical efficacy and tolerability of at-home low-level blue and red light therapy technology in the treatment of mild to moderate acne
- Methicillin-resistant Staphylococcus aureus is an important pathogen in erythrodermic cutaneous T-cell lymphoma patients
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?